Full-Life Technologies

Unleashing the power of half-life to bring a full-life to patients across the world

Full-Life Technologies was founded in 2021, is headquartered in Shanghai, China, lists 51–200 employees, and has $270.3M in recorded funding across 4 rounds.

Headquarters
Shanghai
Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$270.3M
Last Round
$109.0M Series DJan 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 12 investors for this company. The full record is or through the API.

About

Full-Life Technologies Limited is a fully integrated global radiopharmaceuticals company focused on the research, development, production, and commercialization of radiotherapeutic drugs for cancer treatment. The company owns the entire value chain for radiopharmaceuticals — from isotope production and chemistry through clinical development and logistics — enabling it to deliver novel targeted radionuclide therapies directly to patients. Full-Life's pipeline includes compounds that attach radionuclides to targeting vectors (peptides, small molecules, and single-domain antibodies) to deliver therapeutic payloads directly to tumors. Founded in 2021, the company operates across Belgium, Germany, and China, with a state-of-the-art manufacturing facility in Gembloux, Belgium, and operations in Shanghai and Heidelberg. The company has raised over $227 million in financing and counts Vivo Capital and Junson Capital among its investors.

Summary

Full-Life Technologies is a Biotech company based in Shanghai, China, founded in 2021. It lists 51–200 employees. It has raised $270.3M in total across 4 rounds, most recently a $109.0M Series D round in Jan 2026. Investors include Junson Capital, Vivo Capital and Prosperity7 Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries D2026 (est.)
$109.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Full-Life Technologies on Indexed.vc
<a href="https://indexed.vc/companies/full-life-technologies"><img src="https://indexed.vc/api/badge/company/full-life-technologies" alt="Full-Life Technologies on Indexed.vc" width="260" height="76" /></a>